These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37619231)

  • 1. Impact of a non-medical switch from tocilizumab to upadacitinib in a cohort of patients with rheumatoid arthritis in routine clinical practice.
    White D; Poppelwell D
    N Z Med J; 2023 Aug; 136(1581):74-78. PubMed ID: 37619231
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study.
    Dougados M; Kissel K; Conaghan PG; Mola EM; Schett G; Gerli R; Hansen MS; Amital H; Xavier RM; Troum O; Bernasconi C; Huizinga TW
    Ann Rheum Dis; 2014 May; 73(5):803-9. PubMed ID: 24473673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial.
    Humby F; Durez P; Buch MH; Lewis MJ; Rizvi H; Rivellese F; Nerviani A; Giorli G; Mahto A; Montecucco C; Lauwerys B; Ng N; Ho P; Bombardieri M; Romão VC; Verschueren P; Kelly S; Sainaghi PP; Gendi N; Dasgupta B; Cauli A; Reynolds P; Cañete JD; Moots R; Taylor PC; Edwards CJ; Isaacs J; Sasieni P; Choy E; Pitzalis C;
    Lancet; 2021 Jan; 397(10271):305-317. PubMed ID: 33485455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on: tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice.
    Besada E
    Rheumatology (Oxford); 2015 Apr; 54(4):751. PubMed ID: 25602064
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on: tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice: reply.
    Fortunet C; Maillefert JF
    Rheumatology (Oxford); 2015 Apr; 54(4):751-2. PubMed ID: 25602063
    [No Abstract]   [Full Text] [Related]  

  • 6. Dramatic radiographic repair by tocilizumab in a very elderly patient with rheumatoid arthritis.
    Watanabe R; Hirabayashi Y; Okuno H; Ishii T; Harigae H
    Mod Rheumatol; 2014 Nov; 24(6):1028-9. PubMed ID: 24251999
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching.
    Kubo S; Nakayamada S; Nakano K; Hirata S; Fukuyo S; Miyagawa I; Hanami K; Saito K; Tanaka Y
    Ann Rheum Dis; 2016 Jul; 75(7):1321-7. PubMed ID: 26245754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tocilizumab in the management of rheumatoid arthritis.
    Ash Z; Emery P
    Expert Opin Biol Ther; 2012 Sep; 12(9):1277-89. PubMed ID: 22849354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study).
    Kaneko Y; Kato M; Tanaka Y; Inoo M; Kobayashi-Haraoka H; Amano K; Miyata M; Murakawa Y; Yasuoka H; Hirata S; Tanaka E; Miyasaka N; Yamanaka H; Yamamoto K; Takeuchi T;
    Ann Rheum Dis; 2018 Sep; 77(9):1268-1275. PubMed ID: 29853455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocilizumab in patients with active rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs or tumor necrosis factor inhibitors: subanalysis of Spanish results of an open-label study close to clinical practice.
    Álvaro-Gracia JM; Fernández-Nebro A; García-López A; Guzmán M; Blanco FJ; Navarro FJ; Bustabad S; Armendáriz Y; Román-Ivorra JA;
    Reumatol Clin; 2014; 10(2):94-100. PubMed ID: 24099961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effect of tocilizumab on patients with severe active rheumatoid arthritis].
    Xu S; Xie X; Tang M; Chen J; Tian J; Du J; Mao N; Liu Y; Li S; Song M; Gao J; Ling G; Li F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 42(10):1174-1177. PubMed ID: 29093249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of effectiveness, safety and optimization of tocilizumab in a cohort of patients with rheumatoid arthritis in clinical practice.
    Mena-Vázquez N; Manrique-Arija S; Rojas-Giménez M; Ureña-Garnica I; Jiménez-Núñez FG; Fernández-Nebro A
    Reumatol Clin (Engl Ed); 2019; 15(1):21-26. PubMed ID: 28676287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot study.
    Noguchi A; Yasuda S; Hisada R; Kato M; Oku K; Bohgaki T; Suzuki M; Matsumoto Y; Atsumi T
    Mod Rheumatol; 2020 Mar; 30(2):276-281. PubMed ID: 30789096
    [No Abstract]   [Full Text] [Related]  

  • 14. Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice.
    Kaufmann J; Feist E; Roske AE; Schmidt WA
    Clin Rheumatol; 2013 Sep; 32(9):1347-55. PubMed ID: 23703358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [IL-6: the next key target for rheumatoid arthritis after TNF-α].
    Li Y; Zhang W
    Sheng Wu Gong Cheng Xue Bao; 2017 Jan; 33(1):36-43. PubMed ID: 28959861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study.
    Tanaka E; Inoue E; Hoshi D; Shimizu Y; Kobayashi A; Sugimoto N; Shidara K; Sato E; Seto Y; Nakajima A; Momohara S; Taniguchi A; Yamanaka H
    Mod Rheumatol; 2015 Jul; 25(4):503-13. PubMed ID: 25547018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxidermia under treatment with tocilizumab for rheumatoid arthritis.
    Fechtenbaum M; Banse C; Boyard-Lasselin P; Goëb V
    Joint Bone Spine; 2015 Jan; 82(1):69-70. PubMed ID: 25048098
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of tocilizumab in a patient with pyoderma gangrenosum and rheumatoid arthritis.
    Lee WS; Choi YJ; Yoo WH
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):e75-e77. PubMed ID: 27325564
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and efficacy of tocilizumab as monotherapy or in combination with methotrexate in Tunisian patients with active rheumatoid arthritis and inadequate response to disease-modifying anti-rheumatic drugs in conditions close to clinical practice.
    Bouajina E; Zakraoui L; Kchir M; Kochbati S; Baklouti S
    Clin Rheumatol; 2020 May; 39(5):1449-1455. PubMed ID: 31838637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis.
    Malaviya AP; Ledingham J; Bloxham J; Bosworth A; Buch M; Choy E; Cope A; Isaacs J; Marshall D; Wright G; Ostör AJ; ;
    Rheumatology (Oxford); 2014 Jul; 53(7):1344-6. PubMed ID: 24821853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.